Mark Pollack to Drug Therapy, Combination
This is a "connection" page, showing publications Mark Pollack has written about Drug Therapy, Combination.
Connection Strength
1.099
-
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
Score: 0.115
-
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
Score: 0.100
-
Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8.
Score: 0.081
-
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
Score: 0.078
-
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
Score: 0.076
-
Novel treatment approaches for refractory anxiety disorders. Depress Anxiety. 2008; 25(6):467-76.
Score: 0.076
-
An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
Score: 0.067
-
Comorbid anxiety and depression. J Clin Psychiatry. 2005; 66 Suppl 8:22-9.
Score: 0.062
-
Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5.
Score: 0.060
-
Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
Score: 0.056
-
Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8.
Score: 0.051
-
Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
Score: 0.039
-
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
Score: 0.038
-
Treatment of dysphoric mania with nefazodone. Am J Psychiatry. 1996 May; 153(5):732-3.
Score: 0.034
-
Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5.
Score: 0.029
-
Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry. 1993 Nov; 38 Suppl 4:S122-6.
Score: 0.028
-
Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1.
Score: 0.027
-
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
Score: 0.020
-
Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82.
Score: 0.018
-
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
Score: 0.015
-
Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
Score: 0.013
-
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
Score: 0.011
-
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
Score: 0.005